Session: Nuclear Cardiology, Molecular Cardiology, Cardio-Oncology

Nuclear Cardiology, Molecular Cardiology, Cardio-Oncology

Description:

Nuclear cardiology is the study that diagnose and risk strategy of coronary artery disease, myocardial infarction, left ventricular function, detection of right-to-left shunt using nuclear imaging techniques. Nuclear medicine uses radioactive materials, radiotracers that is mostly injected into the blood, indrawn or enveloped. 

Molecular cardiology brings the change in the era by using the molecular biology technique for diagnosis, prevention and treatment of cardio disease. Although this technique is still at the early stage, it has opened a promising avenue for controlling cardiovascular disease and understanding it. 

Cardio-oncology is a rising subspecialty within internal medicine, and particularly in cardiology, which involves the prevention and management of cardiovascular injury from cancer therapies. A minor portion of the field focuses in diagnosing and managing primary/secondary tumours to the heart and the majority focuses on cardiotoxicity from radiotherapy, chemotherapy, and immunotherapy

Related Congress: Heart Congresses | Cardiology Meetings | Cardiology Events 

Related Societies: Cardiology Society; American Heart Association; Japanese Circulation Society; British Junior Cardiologists Association;  Cardiac Society of Australia and New Zealand Sydney, Australia; World Society of Arrhythmias, China; Philippine Heart Association Manila; Asian Society for Cardiovascular Surgery (ASCVS), Asia ; The Pan-African Society of Cardiology (PASCAR)